• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mean platelet volume to lymphocyte ratio may not be a marker for overall survival in non-metastatic clear cell renal cell carcinoma patients treated with nephrectomy.

作者信息

Beyan Cengiz, Beyan Esin

机构信息

Department of Hematology, Ufuk University Faculty of Medicine, 06830, Çankaya, Ankara, Turkey.

Department of Internal Medicine, University of Health Sciences, Kecioren Training and Research Hospital, Kecioren, Ankara, Turkey.

出版信息

Int Urol Nephrol. 2020 Aug;52(8):1453-1454. doi: 10.1007/s11255-020-02436-8. Epub 2020 Mar 5.

DOI:10.1007/s11255-020-02436-8
PMID:32140898
Abstract
摘要

相似文献

1
Mean platelet volume to lymphocyte ratio may not be a marker for overall survival in non-metastatic clear cell renal cell carcinoma patients treated with nephrectomy.平均血小板体积与淋巴细胞比值可能不是接受肾切除术治疗的非转移性透明细胞肾细胞癌患者总生存的标志物。
Int Urol Nephrol. 2020 Aug;52(8):1453-1454. doi: 10.1007/s11255-020-02436-8. Epub 2020 Mar 5.
2
Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy".关于“平均血小板体积与淋巴细胞比值：一种与接受肾切除术治疗的非转移性透明细胞肾细胞癌患者总生存期相关的新型生物标志物”的评论
Int Urol Nephrol. 2020 Sep;52(9):1703. doi: 10.1007/s11255-020-02446-6. Epub 2020 Mar 23.
3
The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.术前和术后中性粒细胞与淋巴细胞比值在肉瘤样肾细胞癌中的预测作用。
Urol Oncol. 2019 Dec;37(12):916-923. doi: 10.1016/j.urolonc.2019.09.006. Epub 2019 Oct 4.
4
Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?术前中性粒细胞与淋巴细胞比值能否预测因肾肿块而行部分肾切除术患者的恶性肿瘤？
Int Braz J Urol. 2018 May-Jun;44(3):461-466. doi: 10.1590/S1677-5538.IBJU.2017.0225.
5
Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging.术前控制营养状况（CONUT）评分作为术前影像学检查≤7cm 非转移性透明细胞肾细胞癌患者生存的新型免疫营养预测因子。
J Cancer Res Clin Oncol. 2019 Apr;145(4):957-965. doi: 10.1007/s00432-019-02846-x. Epub 2019 Feb 13.
6
Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.肾切除术后肾癌患者术前血红蛋白与白蛋白水平及淋巴细胞和血小板计数组合（HALP）的预后意义
BMC Urol. 2018 Mar 15;18(1):20. doi: 10.1186/s12894-018-0333-8.
7
The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及血红蛋白与血小板比值对局限性肾细胞癌肿瘤学结局的影响。
Prog Urol. 2019 Jul-Aug;29(8-9):423-431. doi: 10.1016/j.purol.2019.05.008. Epub 2019 Jun 10.
8
Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma.接受细胞减灭性肾切除术的获益和中性粒细胞与淋巴细胞比值在转移性肾细胞癌患者中的预后作用。
Intern Med J. 2016 Nov;46(11):1291-1297. doi: 10.1111/imj.13202.
9
Prognostic Value of Inflammatory and Nutritional Scores in Renal Cell Carcinoma After Nephrectomy.术后炎性和营养评分在肾细胞癌中的预后价值。
Clin Genitourin Cancer. 2017 Oct;15(5):582-590. doi: 10.1016/j.clgc.2017.04.001. Epub 2017 Apr 27.
10
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.非透明细胞组织学类型的转移性肾细胞癌的减瘤性肾切除术。
J Urol. 2007 Nov;178(5):1896-900. doi: 10.1016/j.juro.2007.07.037. Epub 2007 Sep 17.

引用本文的文献

1
Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3-4, 2020.
Int J Clin Oncol. 2020 Dec;25(12):2177-2178. doi: 10.1007/s10147-020-01815-6. Epub 2020 Oct 26.